Dr. Ankoor Shah
Claim this profileDuke University Medical Center
Studies Systemic Scleroderma
Studies Scleroderma
5 reported clinical trials
9 drugs studied
Area of expertise
1Systemic Scleroderma
Stage I
Stage II
2Scleroderma
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Ankoor Shah is currently running
CABA-201
for Scleroderma
RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis
Recruiting1 award Phase 1 & 22 criteria
Amlitelimab + BI 1015550
for Scleroderma
The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sclerosis.
Recruiting0 awards Phase 2
More about Ankoor Shah
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ankoor Shah has experience with
- Placebo
- Amlitelimab
- BI 1015550
- Brentuximab Vedotin
- Moderna MRNA-1273
- BNT162b2
Breakdown of trials Ankoor Shah has run
Systemic Scleroderma
Scleroderma
Multiple Sclerosis
Systemic Sclerosis
Lung Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ankoor Shah specialize in?
Ankoor Shah focuses on Systemic Scleroderma and Scleroderma. In particular, much of their work with Systemic Scleroderma has involved Stage I patients, or patients who are Stage II.
Is Ankoor Shah currently recruiting for clinical trials?
Yes, Ankoor Shah is currently recruiting for 3 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Ankoor Shah has studied deeply?
Yes, Ankoor Shah has studied treatments such as Placebo, Amlitelimab, BI 1015550.
What is the best way to schedule an appointment with Ankoor Shah?
Apply for one of the trials that Ankoor Shah is conducting.
What is the office address of Ankoor Shah?
The office of Ankoor Shah is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.